Document Detail

Effect of the immunoregulatory cytokines on successful pregnancy depends upon the control of graft rejection mechanisms.
MedLine Citation:
PMID:  17275514     Owner:  NLM     Status:  MEDLINE    
Successful outcomes in allopregnant women depend upon control of graft rejection mechanisms. An understanding of how the fetus escapes the maternal immune system may be relevant for the prevention of transplant rejection. It has been suggested that the same immunosuppressive cytokines contribute to successful pregnancy and transplantation. Recent reports suggest a role for transforming growth factor beta (TGF-beta) in the generation of T-regulatory lymphocytes. In contrast, production of proinflammatory cytokines accompanying intrauterine infection has been associated with fetal rejection or preterm labor. Interleukin-12 (IL-12) is the unique stimulator for differentiation of T-helper lymphocytes (Th) to Th1 cells. It rapidly induces transcription of Th1 cytokines such as interferon-gamma. This study was performed in 70 pregnant women at 21 to 36 weeks gestation, and in 32 healthy nonpregnant controls. An indirect enzyme-linked immunosorbent assay was used to estimate TGF-beta1, and IL-12 in serum. The results showed that TGF-beta1 levels were higher in all pregnant women compared with the nonpregnant controls. No significant changes in serum levels of IL-12 were observed in pregnant compared with the normal control women. The results suggested that the cytokine milieu of the placenta appeared to play a critical role in the maternal acceptance of the fetus, and that TGF-beta1 may function as a regulatory factor in fetal allograft survival during pregnancy.
M Ayatollahi; B Geramizadeh; M Yazdani; N Azarpira
Related Documents :
11102634 - Early pregnancy factor suppresses experimental autoimmune encephalomyelitis induced in ...
14506924 - An immunohistochemical study of the secretory immune system in human fetal membranes an...
18279544 - Management of immune thrombocytopenic purpura in pregnancy.
3585864 - Maternal humoral immune response to incompatibility at multiple minor histocompatibilit...
18366444 - Chronic administration of nevirapine during pregnancy: impact of pregnancy on pharmacok...
8418654 - Quantitation of craniofacial anomalies in utero: fetal alcohol and crouzon syndromes an...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Transplantation proceedings     Volume:  39     ISSN:  0041-1345     ISO Abbreviation:  Transplant. Proc.     Publication Date:    2007 Jan-Feb
Date Detail:
Created Date:  2007-02-05     Completed Date:  2007-04-03     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0243532     Medline TA:  Transplant Proc     Country:  United States    
Other Details:
Languages:  eng     Pagination:  244-5     Citation Subset:  IM    
Transplant Research Center, Namazi Hospital, Transplant Research Center, Shiraz, Iran.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cytokines / therapeutic use*
Enzyme-Linked Immunosorbent Assay
Interleukin-12 / blood*
Pregnancy Outcome
Reference Values
T-Lymphocytes, Regulatory / immunology
Transforming Growth Factor beta / blood*
Reg. No./Substance:
0/Cytokines; 0/Transforming Growth Factor beta; 187348-17-0/Interleukin-12

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Human cord blood cells transplanted into chronically damaged liver exhibit similar characteristics t...
Next Document:  Antioxidant patterns (superoxide dismutase, glutathione reductase, and glutathione peroxidase) in ki...